ERIN GARCIA: Open Payments
NPI 1679805659 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$955 in 50 payments from 17 companies in 2025. Trend: 2023 $2,319 · 2024 $1,371 · 2025 $955
Food & beverage: $955
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $206 |
| Lilly USA, LLC | 6 | $114 |
| Exact Sciences Corporation | 6 | $102 |
| PFIZER INC. | 5 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| ABBVIE INC. | 3 | $56 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $38 |
Products named: Rybelsus, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, NURTEC ODT, REXULTI, AIRSUPRA, GIVLAARI.
Industry payments across TX — which companies pay providers there.
